Dec 16, 2019 Cellectar Announces Data From 20 Patients Receiving a Single 25mCi/M2 Bolus Dose of CLR 131 in the Phase 2 CLOVER-1 Study Learn More
Dec 13, 2019 Cellectar Presents Poster at the American Association for Cancer Research (AACR) San Antonio Breast Cancer Symposium Learn More
Dec 9, 2019 Fractionated Dosing of CLR 131 in Patients with Relapsed or Refractory Multiple Myeloma Presented at the 61st Annual American Society of Hematology Conference Learn More
Dec 2, 2019 Cellectar Announces Oral Presentation at the 61st Annual American Society of Hematology Conference Learn More